A new drug for melanoma could get approval today. The Food and Drug Administration may give the green light to LPI. It's the first drug shown to extend the life of patients with advanced melanoma. A recent study found that one in about 20 patients who took the drug added nearly a year or more to their lives. The drug super-charges the body's immune system to fight the cancer.